← Leaderboards
Anton A. Komar
Cleveland State University
$3,099,220
Attributed
$3,099,220
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $672.8K · FY2014–23$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,099,220 · 3
By mechanism
R01$2,662,720 · 2
R15$436,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland State University
Same institution · by research overlap
- Xue-Long Sun$2,640,204
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroStructureProtein BiosynthesisMessenger RnaAffectTranslationsCodon NucleotidesReportingRecombinantsTransfer RnaProductionRibosome ProfilingGenesProteinsRibosomesBrain HemorrhagePropertyPost-Translational Protein ProcessingOpen Reading FramesPhenotypeProtein ConformationLeadBlood CoagulationHemophilia B
Grant awards (9)
Safer and more effective FIX therapeutics: impact of codon optimization$371,250
R01 · FY2023 · HL · contact PI
eIF2A in translational control$292,046
R01 · FY2023 · GM · contact PI
Safer and more effective FIX therapeutics: impact of codon optimization$371,250
R01 · FY2022 · HL · contact PI
eIF2A in translational control$292,046
R01 · FY2022 · GM · contact PI
Safer and more effective FIX therapeutics: impact of codon optimization$371,250
R01 · FY2021 · HL · contact PI
eIF2A in translational control$292,046
R01 · FY2021 · GM · contact PI
Safer and more effective FIX therapeutics: impact of codon optimization$371,250
R01 · FY2020 · HL · contact PI
eIF2A in translational control$301,582
R01 · FY2020 · GM · contact PI
Understanding the impact of disease causing mutations in FIX$436,500
R15 · FY2014 · HL · contact PI